Bone and mineral disorders after kidney transplantation: Therapeutic strategies |
| |
| Authors: | Miklos Z. Molnar Mohamed S. Naser Connie M. Rhee Kamyar Kalantar-Zadeh Suphamai Bunnapradist |
| |
| Affiliation: | 1. Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA;2. Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;3. Departments of Community Health Sciences and Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA;4. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA |
| |
| Abstract: | Mineral and bone diseases (MBD) are common in patients with chronic kidney disease who undergo kidney transplantation. The incidence, types and severity of MBD vary according to the duration of chronic kidney disease, presence of comorbid conditions and intake of certain medications. Moreover, multiple types of pathology may be responsible for MBD. After successful reversal of uremia by kidney transplantation, many bone and mineral disorders improve, while immunosuppression, other medications, and new and existing comorbidities may result in new or worsening MBD. Chronic kidney disease is also common after kidney transplantation and may impact bone and mineral disease. In this article, we reviewed the prevalence, pathophysiology, and impact of MBD on post-transplant outcomes. We also discussed the diagnostic approach; immunosuppression management and potential treatment of MBD in kidney transplant recipients. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
